Abnormal Metabolism of Steroid Hormone in the Liver of Tumor-Bearing Rats:Changes in Δ<SUP>4</SUP>-Hydrogenase Activity
スポンサーリンク
概要
- 論文の詳細を見る
Δ<SUP>4</SUP>-Hydrogenase is one of the most crucial enzymes in steroid hormone metabolism. The present study was designed to investigate if any change in Δ<SUP>4</SUP>-hydrogenase activity is detected in the liver of tumor-bearing rats.<BR>Through all experiments, Δ<SUP>4</SUP>-hydrogenase activity was determined by Tomkins' method, by measuring the rate of decrease in optical density of three steroid substrates: compounds E, B, and F. Minced rhodamine sarcoma was implanted subcutaneously on the backs of male Wistar rats. After the implantation, the rats were decapitated at weekly intervals for the periods up to six weeks, and the Δ<SUP>4</SUP>-hydrogenase activity of the liver was measured. After the six weeks, all the implanted sarcomas were extirpated, and the Δ<SUP>4</SUP>-hydrogenase activity of the survived rats was further followed for two weeks.<BR>The results of the experiments were given in Fig. 2 and TABLE I. Each point represents an average of the values obtained from five rats. The Δ<SUP>4</SUP>-hydrogenase activity increased in the course of the first week after the implantation, returned almost to normal in the course of the second to third weeks and decreased remarkably in the course of the fourth to sixth weeks. This decrease in the activity, however, rapidly returned to normal in two weeks after extirpation of the sarcomas. The mechanism of the initial increase of the Δ<SUP>4</SUP>-hydrogenase activity is hard to be clarified yet with the present experiment, but it may be possible that the implanted tumor might enhance ACTH secretion, which results in an increased production of steroid hormone and then in a high activity of this enzyme. The decrease in the enzyme activity in the late stage of tumor-growth also is hard to be explained. The decrease in the activity of this enzyme in fasting animals is already noticed by several authors. In the present experiment, the tumor-bearing rats were fasted for 24 hours at the sixth week after tumor implantation. As shown in Fig. 3, further decrease in the Δ<SUP>4</SUP>-hydrogenase activity was observed in the tumorbearing rats which were fasted for 24 hours.<BR>Secondly, 200 micrograms of cortisol or triamcinolone were injected intraperitoneally into each normal rat after 24 hours of fasting. In four hours, the Δ<SUP>4</SUP>-hydrogenase activity in the liver was measured. The results, as shown in Fig. 4, revealed that steroid hormone substrate enhanced the activity of Δ<SUP>4</SUP>-hydrogenase. All the above results were affirmed further by administering 200 micrograms of triamcinolone to each of five rhodamine sarcoma-bearing rats (five weeks after implantation) and five fasting normal rats. The liver homogenate was separated into soluble and microsome fraction in this experiment. The results are illustrated in Fig. 5. Again Δ<SUP>4</SUP>-hydrogenase activity of the liver of the fasting normal animals and the tumor-bearing animals were depressed, and their enzyme activities were increased remarkably after administration of triamcinolone. The degree of increase in the enzyme activity in the tumor bearing-rats was, however, lower than that in the normal fasting animals. The responses to hormone injection of Δ<SUP>4</SUP>-hydrogenase activity was more remarkable in the soluble fraction than in the microsome fraction. The increase of the activity of Δ<SUP>4</SUP>-hydrogenase might be explained as a result of substrate induction or of suppressed break down of the enzyme by the substrate.
著者
-
大塚 英司
東京医科歯科大学大渕内科
-
大淵 重敬
東京医科歯科大学医学部内科学教室
-
河内 卓
国立がんセンター(研)
-
大貫 稔
東京医科歯科大学医学部
-
河内 卓
国立がんセンター研究所生化
-
小西 弦一郎
東京医科歯科大学医学部大淵内科
-
大淵 重敬
東京医科歯科大学医学部大淵内科
関連論文
- 肺結核と肺腫瘍に関する実験的研究(第6報) : 発癌
- ラットにおける肺結核症と肺腫瘍との実験的研究(II報) : 主題I肺癌の発生及び病理
- マウス(ICR系)に於ける結核性瘢痕と肺腫瘍に関する実験的研究 : 主題I肺癌の発生及び病理
- ベンツピレンによるラットの肺腫瘍発生とステロイドホルモン代謝酵素△^4-hydrogenase活性の変動について
- ウレタンによるマウス肺腫瘍発生に及ぼすホルモン投与の影響 : 発癌
- 三年余の経過を追ったAlveolar Cell Carcinomaの1例 : 主題VI肺癌症例示説
- 高等学校水泳選手の合宿練習時における疲労の消長について
- 食品の安全性を再考する
- 20-Methylcholanthrene誘発ラット肺腫瘍の病理組織学的および酵素学的研究 : (V)基礎医学的なもの
- 肺癌2症例の経過とplasma fibrinogen levelおよびblood and urine fibrinolytic activityの変動 : 放射線治療を含めて : (II)治療上からみた肺癌の特異性
- 2.Chemical Mutagens(医薬品の慢性効果)(薬物の特殊毒性)
- 17臨床生化学分析
- 高血圧・動脈硬化性疾患の管理
- 肝線維化進展過程における血漿中Hydroxyproline含有タンパクの意義およびその本態
- Abnormal Metabolism of Steroid Hormone in the Liver of Tumor-Bearing Rats:Changes in Δ4-Hydrogenase Activity
- Significance and Character of Hydroxyproline-Containing Protein in Plasma